119 related articles for article (PubMed ID: 26990689)
1. Estrogen and ERα enhanced β-catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK-3β and β-TrCP expression.
Chen YF; Velmurugan BK; Wang HL; Tu CC; Che RJ; Chen MC; Jen LB; Vishwanadha VP; Hsu HH; Huang CY
Environ Toxicol; 2017 Feb; 32(2):519-529. PubMed ID: 26990689
[TBL] [Abstract][Full Text] [Related]
2. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
[TBL] [Abstract][Full Text] [Related]
3. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
4. Rhubarb inhibits hepatocellular carcinoma cell metastasis via GSK-3-β activation to enhance protein degradation and attenuate nuclear translocation of β-catenin.
Tsai KH; Hsien HH; Chen LM; Ting WJ; Yang YS; Kuo CH; Tsai CH; Tsai FJ; Tsai HJ; Huang CY
Food Chem; 2013 May; 138(1):278-85. PubMed ID: 23265488
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
Hsieh CH; Hsu HH; Shibu MA; Day CH; Bau DT; Ho CC; Lin YM; Chen MC; Wang SH; Huang CY
Mol Carcinog; 2017 Mar; 56(3):1055-1067. PubMed ID: 27648737
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
8. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1.
Wang R; Gao D; Zhou Y; Chen L; Luo B; Yu Y; Li H; Hu J; Huang Q; He M; Peng W; Luo D
J Steroid Biochem Mol Biol; 2017 Nov; 174():276-283. PubMed ID: 29030155
[TBL] [Abstract][Full Text] [Related]
9. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/β-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect.
Hsieh CH; Cheng LH; Hsu HH; Ho TJ; Tu CC; Lin YM; Chen MC; Tsai FJ; Hsieh YL; Huang CY
Biosci Biotechnol Biochem; 2013; 77(12):2397-404. PubMed ID: 24317053
[TBL] [Abstract][Full Text] [Related]
10. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z
Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
13. Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.
Shi Z; Wu X; Ke Y; Wang L
Dig Dis Sci; 2016 Mar; 61(3):785-94. PubMed ID: 26520111
[TBL] [Abstract][Full Text] [Related]
14. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
15. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.
Hsu HH; Cheng SF; Chen LM; Liu JY; Chu CH; Weng YJ; Li ZY; Lin CS; Lee SD; Kuo WW; Huang CY
Mol Cell Biochem; 2006 Sep; 289(1-2):101-9. PubMed ID: 16628468
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
19. ERα/β/DMP1 axis promotes trans-differentiation of chondrocytes to bone cells through GSK-3β/β-catenin pathway.
Yan X; Fan DY; Pi YL; Zhang YN; Fu PJ; Zhang HF
J Anat; 2022 Jun; 240(6):1152-1161. PubMed ID: 35081258
[TBL] [Abstract][Full Text] [Related]
20. SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis.
Tseng RC; Lee SH; Hsu HS; Chen BH; Tsai WC; Tzao C; Wang YC
Cancer Res; 2010 Jan; 70(2):543-51. PubMed ID: 20068157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
